Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.
Belkacemi Y, Latorzeff I, Hasbini A, Coraggio G, Pasquier D, Toledano A, Hennequin C, Bossi A, Chapet O, Crehange G, Guerif S, Duberge T, Allouache N, Clavere P, Gross E, Supiot S, Azria D, Bolla M, Sargos P. Belkacemi Y, et al. Among authors: latorzeff i. Cancer Radiother. 2020 Dec;24(8):892-897. doi: 10.1016/j.canrad.2020.03.014. Epub 2020 Nov 2. Cancer Radiother. 2020. PMID: 33144063 Review.
[Ductal carcinoma in situ: role of the boost].
Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, Bontemps P, Bourgier C, Breton-Callu C, Cowen D, Cretin J, Delalande B, Denis F, Ellis S, Gaci Z, Hannoun-Lévy JM, Hasbini A, Hennequin C, Lagrange JL, Lartigau E, Latorzeff I, Le Blanc-Onfroy M, Lecouillard I, Lemanski C, Levy C, Maingon P, Marchal C, Monnier A, Pradier O, Racadot S, Romestaing P, Serin D, Simon JM, Teyssier E, Tallet A, Tolédano A, Belkacémi Y. Azria D, et al. Among authors: latorzeff i. Cancer Radiother. 2008 Nov;12(6-7):571-6. doi: 10.1016/j.canrad.2008.07.005. Epub 2008 Aug 13. Cancer Radiother. 2008. PMID: 18703372 Review. French.
[Prostate cancer: doses and volumes of radiotherapy].
Hennequin C, Rivera S, Quero L, Latorzeff I. Hennequin C, et al. Among authors: latorzeff i. Cancer Radiother. 2010 Oct;14(6-7):474-8. doi: 10.1016/j.canrad.2010.07.229. Epub 2010 Aug 21. Cancer Radiother. 2010. PMID: 20728390 Review. French.
[Postoperative radiotherapy of prostate cancer].
Richaud P, Sargos P, Henriques de Figueiredo B, Latorzeff I, Mongiat-Artus P, Houédé N, Salomon L, Wallerand H. Richaud P, et al. Among authors: latorzeff i. Cancer Radiother. 2010 Oct;14(6-7):500-3. doi: 10.1016/j.canrad.2010.07.224. Cancer Radiother. 2010. PMID: 20810300 Review. French.
[Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy].
Gérard JP, Aubert B, Buchheit I, Derreumaux S, Lartigau E, Latorzeff I, Lisbona A, Marinello G, Ménéchal P, Porcheron D, Zeghari Squalli N, Isambert A; Working group of the French Nuclear Safety Authority. Gérard JP, et al. Among authors: latorzeff i. Cancer Radiother. 2012 Jun;16 Suppl:S5-9. doi: 10.1016/j.canrad.2011.07.248. Epub 2012 May 9. Cancer Radiother. 2012. PMID: 22578900 French.
[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment].
Pommier P, Morelle M, Perrier L, de Crevoisier R, Laplanche A, Dudouet P, Mahé MA, Chauvet B, Nguyen TD, Créhange G, Zawadi A, Chapet O, Latorzeff I, Bossi A, Beckendorf V, Touboul E, Muracciole X, Bachaud JM, Supiot S, Lagrange JL. Pommier P, et al. Among authors: latorzeff i. Cancer Radiother. 2012 Sep;16(5-6):444-51. doi: 10.1016/j.canrad.2012.07.178. Epub 2012 Aug 27. Cancer Radiother. 2012. PMID: 22951488 Clinical Trial. French.
[Mood and cognitive disorders, and androgen deprivation].
Frémont P, Balardy L, Faramarzi-Roques D, Goldblatt L, Kouri G, Latorzeff I, Mourey L, Pasticier G, Vavdin F, Rischmann P. Frémont P, et al. Among authors: latorzeff i. Prog Urol. 2012 Sep;22 Suppl 2:S64-71. doi: 10.1016/S1166-7087(12)70038-6. Prog Urol. 2012. PMID: 23098792 French.
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M. Gravis G, et al. Among authors: latorzeff i. Lancet Oncol. 2013 Feb;14(2):149-58. doi: 10.1016/S1470-2045(12)70560-0. Epub 2013 Jan 8. Lancet Oncol. 2013. PMID: 23306100 Clinical Trial.
[Hypofractionated radiotherapy in prostate cancer].
Supiot S, Créhange G, Latorzeff I, Pommier P, Paumier A, Rio E, Delaroche G, Guérif S, Catton C, Martin J, Lisbona A. Supiot S, et al. Among authors: latorzeff i. Cancer Radiother. 2013 Oct;17(5-6):349-54. doi: 10.1016/j.canrad.2013.05.005. Epub 2013 Aug 20. Cancer Radiother. 2013. PMID: 23973460 Review. French.
125 results